Skip to main content
Clinical Trials/NCT07454200
NCT07454200
Not yet recruiting
Not Applicable

Feasibility, Acceptability, and Preliminary Effectiveness of a Hatha Yoga-on Reminiscence Functions and Mindfulness in Patients Hospitalized for Schizophrenia

The Hashemite University0 sites36 target enrollmentStarted: April 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
36
Primary Endpoint
The Five-Facet Mindfulness Questionnaire-15 (FFMQ-15)

Overview

Brief Summary

The current study aims to examine the feasibility, acceptability, and preliminary effectiveness of a Hatha yoga-based group intervention on reminiscence functions and mindfulness in a sample of patients hospitalized for schizophrenia.

Detailed Description

This study employs a mixed-methods sequential explanatory design. Convenience sampling will be used to recruit 36 participants for a cross-culturally adapted Hatha yoga-based group intervention (16 one hour-long sessions over 8 weeks). Feasibility indicators will be monitored systematically. Acceptability will be assessed using semi-structured interviews. Preliminary effectiveness will be evaluated using a quasi-experimental one-group pre-post test design to test group-level (paired t-test) and individual-level (reliability change index) changes in mindfulness and reminiscence functions. Thematic analysis will be conducted to analyze qualitative data, with meta-inference used to integrate the qualitative and quantitative findings.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 64 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients are diagnosed with schizophrenia according to the DSM-5-TR or ICD-10 criteria
  • Patients are aged between 18 and 65 years old
  • Patients are clinically stabile, defined as being in the post-acute phase of care with no acute psychotic episode or psychiatric hospitalization within the 30 days preceding enrollment
  • Patients have adequate cognitive functioning, as evidenced by passing the Mini-Mental State Examination (MMSE), with sufficient insight and capacity to respond meaningfully to study procedures
  • Patients have the ability to attend group-based sessions and provide informed consent
  • Patients have the willingness and physical ability to engage safely in light-to-moderate yoga practice.

Exclusion Criteria

  • Patients with severe cognitive impairment or intellectual disability that would disqualify meaningful participation
  • Patients with acute psychiatric symptoms or active suicidal ideation
  • Patients with physical limitations, such as a severe musculoskeletal condition, that would contraindicate safe participation in yoga practice.

Arms & Interventions

Experimental

Experimental

Hatha Yoga-Based Group Intervention

Intervention: Intervention Arm: Hatha Yoga (Behavioral)

Outcomes

Primary Outcomes

The Five-Facet Mindfulness Questionnaire-15 (FFMQ-15)

Time Frame: 12 weeks

The Five-Facet Mindfulness Questionnaire-15 is a 15-item self-report measure assessing five domains: observing, describing, acting with awareness, nonjudging, and nonreactivity. Each item is rated on a 5-point Likert scale from 1 to 5. Total scores range from 15 to 75. Higher scores indicate higher levels of dispositional mindfulness, reflecting a better outcome.

Feasibility Indicators: Recruitment Retention Attrition Adherence Data completeness Adverse events.

Time Frame: 10 weeks

1. Recruitment rate: Percentage of eligible participants enrolled during the 10-week recruitment period, calculated as the number who provide written consent divided by the total eligible participants approached, multiplied by 100. 2. Retention rate: Percentage of enrolled participants who complete the week 10 assessment, calculated as completers divided by total enrolled at baseline, multiplied by 100. 3. Attrition rate: Percentage of participants who withdraw before week 10, calculated as discontinuations divided by total enrolled, multiplied by 100. 4. Adherence: Attendance rate across scheduled sessions, calculated as sessions attended divided by total sessions, multiplied by 100. 5. Data completeness: Percentage of completed outcome assessment items at baseline and week 10, calculated as completed items divided by total expected items, multiplied by 100. 6. Adverse events: Number and proportion of participants experiencing adverse events during the intervention period.

Secondary Outcomes

  • The 18-item Tripartite Adjusted Arabic Reminiscence Functions Scale (AARFS-tri)(12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Abdallah Abu Khait

Dr.

The Hashemite University

Similar Trials